|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the EYE 10-K filed Mar 1, 2007. Phacoemulsification
Systems. We are a leading provider of phacoemulsification
systems, and have a range of systems to meet market needs. Phacoemulsification
systems use disposable or reusable packs that are necessary to operate the
equipment. The majority of our phacoemulsification product sales are from sales
of these packs and related accessories. Sales of our phacoemulsification
products represented approximately 9% of our net sales in 2006 and 2005 and 10%
of our net sales in 2004.
We currently market the following phacoemulsification systems: · Sovereign — our premier phacoemulsification system is designed to reduce procedure times and provide the surgeon with increased control. The Sovereign system is available with our proprietary Occlusion Mode and WhiteStar technology, which creates less heat and turbulence in the ocular environment, giving rise to the term “cold phaco” and enabling better patient outcomes. Our WhiteStar technology also permits the system to offer bimanual, micro-incision phaco, a procedure which gives surgeons more operating flexibility over traditional techniques. · Sovereign Compact -is a mid-sized phacoemulsification system designed to meet surgeons’ needs for an advanced phacoemulsification system, with the similar functionality of the Sovereign system, in a smaller, more portable size. The Sovereign Compact system is also available with Occlusion Mode and WhiteStar technology. · Diplomax II — is a small-sized phacoemulsification system designed for surgeons who need a less expensive and more portable machine. These systems do not include WhiteStar technology, but do employ Occlusion Mode technology. This excerpt taken from the EYE 10-K filed Mar 14, 2006. Phacoemulsification
Systems. We are a leading provider of phacoemulsification
systems, and have a range of systems to meet market needs. Phacoemulsification
systems use disposable or reusable packs that are necessary to operate the
equipment. The majority of our phacoemulsification product sales are from sales
of these packs and related accessories. Sales of our phacoemulsification
products represented approximately 9%, 10% and 11% of our net sales in 2005,
2004 and 2003, respectively.
We currently market the following phacoemulsification systems:
• | EXCERPTS ON THIS PAGE:
RELATED TOPICS for EYE: |
| |||||||
